DK1054671T3 - Ny anvendelse til smertebehandling - Google Patents

Ny anvendelse til smertebehandling

Info

Publication number
DK1054671T3
DK1054671T3 DK99903972T DK99903972T DK1054671T3 DK 1054671 T3 DK1054671 T3 DK 1054671T3 DK 99903972 T DK99903972 T DK 99903972T DK 99903972 T DK99903972 T DK 99903972T DK 1054671 T3 DK1054671 T3 DK 1054671T3
Authority
DK
Denmark
Prior art keywords
new application
pain management
pain
muskuloskeletal
ropivacaine
Prior art date
Application number
DK99903972T
Other languages
Danish (da)
English (en)
Inventor
Goeran Isacsson
Dag Selander
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1054671T3 publication Critical patent/DK1054671T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
DK99903972T 1998-01-21 1999-01-11 Ny anvendelse til smertebehandling DK1054671T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use
PCT/SE1999/000012 WO1999037301A1 (en) 1998-01-21 1999-01-11 New use for pain management

Publications (1)

Publication Number Publication Date
DK1054671T3 true DK1054671T3 (da) 2003-02-24

Family

ID=20409917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99903972T DK1054671T3 (da) 1998-01-21 1999-01-11 Ny anvendelse til smertebehandling

Country Status (11)

Country Link
US (2) US6395291B1 (pt)
EP (1) EP1054671B1 (pt)
JP (1) JP4456754B2 (pt)
AT (1) ATE228840T1 (pt)
AU (1) AU2444399A (pt)
DE (1) DE69904297T2 (pt)
DK (1) DK1054671T3 (pt)
ES (1) ES2189386T3 (pt)
PT (1) PT1054671E (pt)
SE (1) SE9800139D0 (pt)
WO (1) WO1999037301A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611217A (en) * 2005-12-06 2006-04-01 Shin Hwa Biotech Co Ltd Human model for indexing nerve paths (locus) having corresponding relations and method for indexing
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
CA2898933A1 (en) * 2014-07-30 2016-01-30 Grigory Karmy Method for relieving chronic pain
US10751249B2 (en) * 2017-11-26 2020-08-25 Johnson Athletic Advantage LLC Trigger point dry needling in motion and method of use
BE1026845B1 (nl) 2018-12-07 2020-07-08 Fagron Compounding Services Nv Samenstelling voor gebruik in lokale infiltratie analgesie (LIA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE40994T1 (de) 1983-08-01 1989-03-15 Astra Laekemedel Ab L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
SE451840B (sv) 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9401174D0 (sv) 1994-04-07 1994-04-07 Astra Ab New combination
JP2001515492A (ja) 1997-03-13 2001-09-18 エヌ． キャンベル，ジェイムズ カプサイシンまたはカプサイシンアナログを含有する組成物および局所麻酔

Also Published As

Publication number Publication date
WO1999037301A1 (en) 1999-07-29
US6395291B1 (en) 2002-05-28
SE9800139D0 (sv) 1998-01-21
DE69904297D1 (de) 2003-01-16
US6620423B2 (en) 2003-09-16
JP2002501021A (ja) 2002-01-15
PT1054671E (pt) 2003-03-31
JP4456754B2 (ja) 2010-04-28
ES2189386T3 (es) 2003-07-01
AU2444399A (en) 1999-08-09
EP1054671A1 (en) 2000-11-29
DE69904297T2 (de) 2003-08-21
US20020156101A1 (en) 2002-10-24
EP1054671B1 (en) 2002-12-04
ATE228840T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
AR029707A1 (es) Utilizacion de un compuesto metalo-organico para proteger y/o reforzar las materias queratinicas, y procedimiento de tratamiento
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
DE60141230D1 (de) Verwendung von Botulinum Toxin zur Behandlung von neuralgischen Schmerzen
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
AR025964A1 (es) Tratamiento nasal topico
ID29095A (id) Antagonis mglur5 untuk pengobatan rasa sakit dan kegelisahan
ID21863A (id) Senyawa kinolin dan kinazolin yangberguna dalam terapi, khususnya dalam pengobatan heperplasia prostatik jinak
EA200000351A1 (ru) Лечение кондуктивных нарушений
UY25712A1 (es) Benzamidas sustituidas y su aplicación en medicamentos
DE602004005814D1 (de) Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
DE60139466D1 (de) Behandlung von diabetes
DE60106233D1 (de) Verwendung von ellagsäure zum schutz gegen verschmutzung
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
ATE275919T1 (de) Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen
DK1054671T3 (da) Ny anvendelse til smertebehandling
NZ513851A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69924979D1 (de) Behandlung von chronischen schmerzen
TR200002939T2 (tr) Paroksetin maleat
DK1150682T3 (da) Ubichinon Qn til behandling af migrænesmerter
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
DK1042288T3 (da) Tripeptidyl-peptidase inhibitorer